Galecto Inc reports results for the quarter ended in September 30 - Earnings Summary

• Galecto Inc GGLTO reported a quarterly adjusted loss of $3.39​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-7.50. The mean expectation of two analysts for the quarter was for a loss of $4.10 per share. Wall Street expected results to range from $-4.50 to $-3.70 per share.

• Reported revenue was zero​; analysts expected zero.

• Galecto Inc's reported EPS for the quarter was a loss of $3.39​.

• The company reported a quarterly loss of $3.88 million.

• Galecto Inc shares had fallen by 43.6% this quarter and lost 61.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 25.4% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Galecto Inc is $10.00

This summary was machine generated from LSEG data November 2 at 02:12 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)